Jonathan Yap
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan Yap has a total of 622 co-authors. Here are the top co-authors by number of shared publications:
- Khung Keong Yeo
National Heart Center Singapore, Singapore, Singapore
33 shared publications - Jack Wei Chieh Tan
Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore
12 shared publications See Hooi Ewe
National Heart Centre Singapore
9 shared publicationsSoo Teik Lim
Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore
8 shared publications- Kay Woon Ho
National Heart Centre Singapore
7 shared publications Khung Keong Yeo
Department of Cardiology, National Heart Centre Singapore, Singapore; Duke-NUS Medical School, Singapore
7 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Evaluating the Low‐Density Lipoprotein Cholesterol Paradox in Heart Failure With Reduced Ejection Fraction
Background: Hypercholesterolemia is an established cardiovascular risk factor. However, studies in patients with heart failure with reduced ejection fraction (HFrEF) showed an association between low low‐density lipoprotein cholesterol (LDL‐C) and increased mortality, termed the “LDL‐C paradox.” This study examined the impact of LDL‐C on clinical outcomes in patients with HFrEF and identify distinct hypocholesterolemia subgroups using latent class analysis. Methods: Consecutive patients with HFrEF (left ventricular EF P P P P =0.037), and the subgroup with nonpathological hypocholesterolemia showed comparable outcomes. Conclusions: A distinct subset of patients with HFrEF with low LDL‐C demonstrates different clinical characteristics (older and higher comorbidity burden) and poorer outcomes, potentially elucidating the “LDL‐C paradox” cause in patients with HFrEF.
- 12 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Open AccessEvaluating the Low‐Density Lipoprotein Cholesterol Paradox in Heart Failure With Reduced Ejection Fraction
Background: Hypercholesterolemia is an established cardiovascular risk factor. However, studies in patients with heart failure with reduced ejection fraction (HFrEF) showed an association between low low‐density lipoprotein cholesterol (LDL‐C) and increased mortality, termed the “LDL‐C paradox.” This study examined the impact of LDL‐C on clinical outcomes in patients with HFrEF and identify distinct hypocholesterolemia subgroups using latent class analysis. Methods: Consecutive patients with HFrEF (left ventricular EF P P P P =0.037), and the subgroup with nonpathological hypocholesterolemia showed comparable outcomes. Conclusions: A distinct subset of patients with HFrEF with low LDL‐C demonstrates different clinical characteristics (older and higher comorbidity burden) and poorer outcomes, potentially elucidating the “LDL‐C paradox” cause in patients with HFrEF.
- Open Access
- 22 October 2026
- Published by SAGE Publications in Proceedings of Singapore Healthcare
- Vol. 35
Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: A review
Coronary artery obstruction is an uncommon but serious complication of transcatheter aortic valve replacement (TAVR) with significant morbidity and mortality. Transcatheter electrosurgical aortic leaflet laceration (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction [BASILICA]) was developed to prevent coronary artery obstruction in suitable individuals at high-risk of coronary obstruction undergoing TAVR. This study aims to evaluate the efficacy and safety of the BASILICA technique by performing a review of the available literature. A literature search for relevant studies till August 2024 was undertaken. Procedural success was defined as successful leaflet traversal and laceration. Safety outcomes included mortality (cardiovascular and non-cardiovascular), stroke, coronary artery obstruction, major vascular complications, life-threatening bleeds, acute kidney injury or valve-related complications requiring further procedures. 9 observational studies involving 384 patients were included. 303 were single BASILICA while 81 were doppio BASILICA procedures; 81 involved the native aortic valve, while 303 involved bioprosthetic aortic valves. 16 patients had balloon-augmented BASILICA. The overall procedure success rate was 90.9% (349/384). The potential/definite coronary obstruction rate was 7% (27/384). 6.7% (25/372) required subsequent percutaneous coronary intervention and 0.9% (2/235) required snaring of initial TAVR valve into the ascending aorta and deployment of a second valve. The 30-day/in-hospital mortality rate was 2.1% (8/384). None required emergency open-heart surgery and 1.3% (4/311) required mechanical circulatory support. In experienced hands, BASILICA is a reasonable and potentially valuable alternative in appropriately selected individuals at high risk of coronary obstruction undergoing TAVR.
- 22 October 2026
- Published by SAGE Publications in Proceedings of Singapore Healthcare
- Vol. 35
Open AccessTranscatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: A review
Coronary artery obstruction is an uncommon but serious complication of transcatheter aortic valve replacement (TAVR) with significant morbidity and mortality. Transcatheter electrosurgical aortic leaflet laceration (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction [BASILICA]) was developed to prevent coronary artery obstruction in suitable individuals at high-risk of coronary obstruction undergoing TAVR. This study aims to evaluate the efficacy and safety of the BASILICA technique by performing a review of the available literature. A literature search for relevant studies till August 2024 was undertaken. Procedural success was defined as successful leaflet traversal and laceration. Safety outcomes included mortality (cardiovascular and non-cardiovascular), stroke, coronary artery obstruction, major vascular complications, life-threatening bleeds, acute kidney injury or valve-related complications requiring further procedures. 9 observational studies involving 384 patients were included. 303 were single BASILICA while 81 were doppio BASILICA procedures; 81 involved the native aortic valve, while 303 involved bioprosthetic aortic valves. 16 patients had balloon-augmented BASILICA. The overall procedure success rate was 90.9% (349/384). The potential/definite coronary obstruction rate was 7% (27/384). 6.7% (25/372) required subsequent percutaneous coronary intervention and 0.9% (2/235) required snaring of initial TAVR valve into the ascending aorta and deployment of a second valve. The 30-day/in-hospital mortality rate was 2.1% (8/384). None required emergency open-heart surgery and 1.3% (4/311) required mechanical circulatory support. In experienced hands, BASILICA is a reasonable and potentially valuable alternative in appropriately selected individuals at high risk of coronary obstruction undergoing TAVR.
- Open Access
- 14 October 2026
- Published by Springer Nature in BMC Public Health
Prevalence of hypertension phenotypes in an urban population with low cardiovascular risk in Singapore: a cross-sectional study
Background: Global reports on hypertension phenotypes exist, but population‑based evidence remains limited. A significant gap also persists in understanding these phenotypes within multi‑ethnic urban populations. Thus, this study aimed to determine the prevalence of hypertension phenotypes and their associated factors in a low-risk population in Singapore. Methods: The cross-sectional study analysed data from 981 adults aged 21–69 years with a low 10-year cardiovascular risk (based on the 2023 Singapore modified Framingham risk score) and not on any antihypertensives. Participants were recruited from public or clinic settings using convenience sampling. Following consent, participants completed clinical examinations and investigations using structured questionnaires and validated instruments, such as office BP and 24-hour ambulatory BP monitoring (ABPM) devices. Results: The mean age of the participants was 45.5 years (SD 11.8 years). Most were females (51.6%) and of Chinese ethnicity (91.2%). Normal body mass index (BMI) and waist circumference were observed in 47.0% and 60.7% of the cohort, respectively. Lifestyle data revealed that most participants were nonsmokers (90.9%) and engaged in physical activity (81.3%). The prevalence of hypertension was 25.5% by office BP and 22.7% by 24-hour ABPM, with 38.5% diagnosed via any ABPM target. Nocturnal hypertension (NH) was the most prevalent hypertension phenotype (36.1%), while white-coat hypertension had the lowest prevalence (6.5%). Daytime hypertension and masked hypertension (MH) were observed in 17.4% and 19.4% of participants, respectively. A non-dipping (ND) BP pattern was identified in 59.7% of the cohort. Conclusion: This study revealed a high prevalence of NH and ND, with MH emerging as the next most common phenotype in a low-risk, urban Singaporean population. These findings support the potential role of ABPM to unmask hypertension phenotypes. Longitudinal follow up of this cohort could determine their prognostic significance and implications for cardiovascular risk stratification.
- 14 October 2026
- Published by Springer Nature in BMC Public Health
Open AccessPrevalence of hypertension phenotypes in an urban population with low cardiovascular risk in Singapore: a cross-sectional study
Background: Global reports on hypertension phenotypes exist, but population‑based evidence remains limited. A significant gap also persists in understanding these phenotypes within multi‑ethnic urban populations. Thus, this study aimed to determine the prevalence of hypertension phenotypes and their associated factors in a low-risk population in Singapore. Methods: The cross-sectional study analysed data from 981 adults aged 21–69 years with a low 10-year cardiovascular risk (based on the 2023 Singapore modified Framingham risk score) and not on any antihypertensives. Participants were recruited from public or clinic settings using convenience sampling. Following consent, participants completed clinical examinations and investigations using structured questionnaires and validated instruments, such as office BP and 24-hour ambulatory BP monitoring (ABPM) devices. Results: The mean age of the participants was 45.5 years (SD 11.8 years). Most were females (51.6%) and of Chinese ethnicity (91.2%). Normal body mass index (BMI) and waist circumference were observed in 47.0% and 60.7% of the cohort, respectively. Lifestyle data revealed that most participants were nonsmokers (90.9%) and engaged in physical activity (81.3%). The prevalence of hypertension was 25.5% by office BP and 22.7% by 24-hour ABPM, with 38.5% diagnosed via any ABPM target. Nocturnal hypertension (NH) was the most prevalent hypertension phenotype (36.1%), while white-coat hypertension had the lowest prevalence (6.5%). Daytime hypertension and masked hypertension (MH) were observed in 17.4% and 19.4% of participants, respectively. A non-dipping (ND) BP pattern was identified in 59.7% of the cohort. Conclusion: This study revealed a high prevalence of NH and ND, with MH emerging as the next most common phenotype in a low-risk, urban Singaporean population. These findings support the potential role of ABPM to unmask hypertension phenotypes. Longitudinal follow up of this cohort could determine their prognostic significance and implications for cardiovascular risk stratification.
- Open Access
- 22 June 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 460, 134638
Clinical and artificial intelligence assessed echocardiographic predictors of outcomes after acute myocardial infarction
- 22 June 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 460, 134638
Open AccessClinical and artificial intelligence assessed echocardiographic predictors of outcomes after acute myocardial infarction
- Open Access
- 3 June 2026
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 55 (7)
Transcatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience
Aortic regurgitation (AR) is a common valvular heart disease, with a cohort study reporting an approximate prevalence of 13% in men and 8.5% in women.1 Severe AR portends significant mortality and morbidity if untreated.2 Aortic valve surgery remains the gold standard for management.3 However, a significant proportion are treated conservatively because of high surgical risks, significant comorbidities, or the patient’s refusal of surgery.4 Despite the success of transcatheter aortic valve implantation (TAVI) for the management of aortic stenosis (AS), existing devices have not been designed for the treatment of AR. In patients with limited surgical options, these devices have been used off-label with higher associated risks.5 The recent development of dedicated devices has changed the landscape.6,7 In particular, the ALIGN-AR study demonstrated the safety and efficacy of the use of the Trilogy transcatheter heart valve (THV) (JenaValve Technology, Irvine, CA, US) in treating patients with severe tricuspid AR.7 The Trilogy valve is a porcine pericardial THV composed of 3 leaflets within a self-expanding nitinol stent scaffold. It has 3 locators which are centred on the native aortic cusps, limiting implant depth and allowing clipping to the native leaflets for secure anchoring.7 To the authors’ knowledge, this is the first case series in Southeast Asia (SEA) to describe the initial experience with the Trilogy THV for the treatment of severe tricuspid AR.
- 3 June 2026
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 55 (7)
Open AccessTranscatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience
Aortic regurgitation (AR) is a common valvular heart disease, with a cohort study reporting an approximate prevalence of 13% in men and 8.5% in women.1 Severe AR portends significant mortality and morbidity if untreated.2 Aortic valve surgery remains the gold standard for management.3 However, a significant proportion are treated conservatively because of high surgical risks, significant comorbidities, or the patient’s refusal of surgery.4 Despite the success of transcatheter aortic valve implantation (TAVI) for the management of aortic stenosis (AS), existing devices have not been designed for the treatment of AR. In patients with limited surgical options, these devices have been used off-label with higher associated risks.5 The recent development of dedicated devices has changed the landscape.6,7 In particular, the ALIGN-AR study demonstrated the safety and efficacy of the use of the Trilogy transcatheter heart valve (THV) (JenaValve Technology, Irvine, CA, US) in treating patients with severe tricuspid AR.7 The Trilogy valve is a porcine pericardial THV composed of 3 leaflets within a self-expanding nitinol stent scaffold. It has 3 locators which are centred on the native aortic cusps, limiting implant depth and allowing clipping to the native leaflets for secure anchoring.7 To the authors’ knowledge, this is the first case series in Southeast Asia (SEA) to describe the initial experience with the Trilogy THV for the treatment of severe tricuspid AR.
- 11 May 2026
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 102 (1211) , 847-854
Understanding the cardiology training landscape in Asia-Pacific region
Background: Considerable diversity in cardiology training and credentialing pathways exist within the Asia-Pacific. We aimed to map these variations and report similarities and disparities with a view to understanding needs in cardiology curricula development in the region. Methods: A 42-item online questionnaire was distributed to credentialed cardiologists serving as representatives from various regions within the Asia-Pacific, allowing obtainment of region-specific data as of December 2023. Responses were derived from a total of 23 regions. Results: All regions required specialist qualification to practise cardiology. Overall, 69.6% have a single training pathway, while 21.7% and 8.7% have two or three pathways, respectively. Majority (91.3%) had structured cardiology training curricula with assigned supervisor and regular assessments. The majority (91.3%) required mandatory training in internal medicine prior to cardiology. The total training duration inclusive of medicine and cardiology varied across regions (range 3–8 years) with 26.1% lasting 5 years and 43.5% lasting 6 years. All programmes had mandatory clinical cardiology training; 82.6% had interventional cardiology, 73.9% had electrophysiology, 73.9% had cardiac imaging training. However, 47.8% of regions had no training in cardiac computerized tomography (CT) and 56.5% had no cardiac magnetic resonance (CMR) imaging. 73.9% required mandatory research for board certification. In addition, 95.1% had an exit exam at completion of training (local in 95% cases). Board certification was mandatory for general cardiology practise in 69.6% of regions. Separate subspeciality fellowships were mandatory in 73.9% of regions. Conclusions: Significant regional variations in cardiology training and credentialing pathways exist, presenting opportunities to harmonize and improve training metrics regionally. Key message What is already known on the topic? Cardiology training within the Asia-Pacific region has considerable variation in terms of duration, curriculum, training, and exit requirements. What this study adds? This study outlines the similarities and differences of cardiology training between different countries within the Asia-Pacific region. How this study might affect research, practise or policy? Results from this study provide insights that may inform the development of harmonized and contextually appropriate cardiology curricula in the Asia-Pacific region. Establishing common standards for cardiology training could facilitate a more uniform and coherent curriculum across Asia, ensuring consistency in trainee competencies and clinical practise.
- 11 May 2026
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 102 (1211) , 847-854
Understanding the cardiology training landscape in Asia-Pacific region
Background: Considerable diversity in cardiology training and credentialing pathways exist within the Asia-Pacific. We aimed to map these variations and report similarities and disparities with a view to understanding needs in cardiology curricula development in the region. Methods: A 42-item online questionnaire was distributed to credentialed cardiologists serving as representatives from various regions within the Asia-Pacific, allowing obtainment of region-specific data as of December 2023. Responses were derived from a total of 23 regions. Results: All regions required specialist qualification to practise cardiology. Overall, 69.6% have a single training pathway, while 21.7% and 8.7% have two or three pathways, respectively. Majority (91.3%) had structured cardiology training curricula with assigned supervisor and regular assessments. The majority (91.3%) required mandatory training in internal medicine prior to cardiology. The total training duration inclusive of medicine and cardiology varied across regions (range 3–8 years) with 26.1% lasting 5 years and 43.5% lasting 6 years. All programmes had mandatory clinical cardiology training; 82.6% had interventional cardiology, 73.9% had electrophysiology, 73.9% had cardiac imaging training. However, 47.8% of regions had no training in cardiac computerized tomography (CT) and 56.5% had no cardiac magnetic resonance (CMR) imaging. 73.9% required mandatory research for board certification. In addition, 95.1% had an exit exam at completion of training (local in 95% cases). Board certification was mandatory for general cardiology practise in 69.6% of regions. Separate subspeciality fellowships were mandatory in 73.9% of regions. Conclusions: Significant regional variations in cardiology training and credentialing pathways exist, presenting opportunities to harmonize and improve training metrics regionally. Key message What is already known on the topic? Cardiology training within the Asia-Pacific region has considerable variation in terms of duration, curriculum, training, and exit requirements. What this study adds? This study outlines the similarities and differences of cardiology training between different countries within the Asia-Pacific region. How this study might affect research, practise or policy? Results from this study provide insights that may inform the development of harmonized and contextually appropriate cardiology curricula in the Asia-Pacific region. Establishing common standards for cardiology training could facilitate a more uniform and coherent curriculum across Asia, ensuring consistency in trainee competencies and clinical practise.
- Open Access
- 5 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (5) , 736-745
Development of a Noninvasive Prediction Score for Post-Capillary Pulmonary Hypertension in a Multi-Ethnic Asian Population
- 5 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (5) , 736-745
Open AccessDevelopment of a Noninvasive Prediction Score for Post-Capillary Pulmonary Hypertension in a Multi-Ethnic Asian Population
- Open Access
- 27 April 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Management of Stable Coronary Artery Disease in the Asia-Pacific Region: Perspectives Among Different Cardiovascular Subspecialities
Limited data exist regarding subspeciality variation in the management of stable coronary artery disease within cardiology. In this multinational cross-sectional survey of 618 cardiologists across Asia-Pacific countries, including 233 interventional cardiologists (ICs), we analysed differences in knowledge, attitude and practices of ICs versus non-ICs using Wilcoxon signed-rank tests. Predictors of revascularisation were assessed via logistic regression. Although ICs had better knowledge of the guidelines than non-ICs, they exhibited poorer perception of treatment for stable coronary artery disease. Despite guideline recommendations for medical therapy, ICs were more likely to choose revascularisation across all case scenarios. Interventional subspeciality was the only significant predictor of preferentially choosing revascularisation. Future efforts can be focused on bridging the discrepancy between guidelines and practice.
- 27 April 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Open AccessManagement of Stable Coronary Artery Disease in the Asia-Pacific Region: Perspectives Among Different Cardiovascular Subspecialities
Limited data exist regarding subspeciality variation in the management of stable coronary artery disease within cardiology. In this multinational cross-sectional survey of 618 cardiologists across Asia-Pacific countries, including 233 interventional cardiologists (ICs), we analysed differences in knowledge, attitude and practices of ICs versus non-ICs using Wilcoxon signed-rank tests. Predictors of revascularisation were assessed via logistic regression. Although ICs had better knowledge of the guidelines than non-ICs, they exhibited poorer perception of treatment for stable coronary artery disease. Despite guideline recommendations for medical therapy, ICs were more likely to choose revascularisation across all case scenarios. Interventional subspeciality was the only significant predictor of preferentially choosing revascularisation. Future efforts can be focused on bridging the discrepancy between guidelines and practice.
- Open Access
- 27 April 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Clinical and Genetic Determinants of Subclinical Coronary Atherosclerosis in Healthy Asian People
Background: Genetic determinants may offer incremental value over routine clinical risk factors for the prediction of coronary atherosclerosis, possibly with different outcomes across populations. Methods: In Asian subjects without known cardiovascular disease and/or diabetes, coronary atherosclerosis was quantified by coronary artery calcium (CAC), with a score of ≥100 indicating moderate-severe calcification. Relevant single nucleotide polymorphisms (SNPs) were identified through published studies with genotypes extracted through whole genome sequencing. Multivariate logistic regression modelling was performed to derive a clinical, genetic and combined model. Models’ performance was assessed using the area under the curve (AUC), Akaike’s information criterion (AIC), and Brier score. Results: Of 845 participants, 74 individuals (8.8%) had a CAC score of at least 100. Independent clinical predictors of a CAC score ≥100 were higher age, male sex, higher systolic blood pressure, higher glucose, longer time asleep, larger number of daily steps and family history of ischemic heart disease. This clinical model had an AUC of 0.89, AIC of 323, and Brier score of 0.0570. The genetic model, with independent SNPs rs515135, rs2047009 and rs10757272, had an AUC of 0.64 (p<0.001 versus clinical model), AIC of 444, and Brier score of 0.0831. The combined model had an AUC of 0.91 (p=0.0026 versus clinical model), AIC of 280, and Brier score of 0.0570. Conclusion: In this healthy Asian cohort, a purely genetic prediction model for moderate-severe subclinical coronary atherosclerosis did not perform as well as its clinical counterpart. Incorporating both clinical and genetic variables allowed for only minor incremental predictive capabilities.
- 27 April 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Open AccessClinical and Genetic Determinants of Subclinical Coronary Atherosclerosis in Healthy Asian People
Background: Genetic determinants may offer incremental value over routine clinical risk factors for the prediction of coronary atherosclerosis, possibly with different outcomes across populations. Methods: In Asian subjects without known cardiovascular disease and/or diabetes, coronary atherosclerosis was quantified by coronary artery calcium (CAC), with a score of ≥100 indicating moderate-severe calcification. Relevant single nucleotide polymorphisms (SNPs) were identified through published studies with genotypes extracted through whole genome sequencing. Multivariate logistic regression modelling was performed to derive a clinical, genetic and combined model. Models’ performance was assessed using the area under the curve (AUC), Akaike’s information criterion (AIC), and Brier score. Results: Of 845 participants, 74 individuals (8.8%) had a CAC score of at least 100. Independent clinical predictors of a CAC score ≥100 were higher age, male sex, higher systolic blood pressure, higher glucose, longer time asleep, larger number of daily steps and family history of ischemic heart disease. This clinical model had an AUC of 0.89, AIC of 323, and Brier score of 0.0570. The genetic model, with independent SNPs rs515135, rs2047009 and rs10757272, had an AUC of 0.64 (p<0.001 versus clinical model), AIC of 444, and Brier score of 0.0831. The combined model had an AUC of 0.91 (p=0.0026 versus clinical model), AIC of 280, and Brier score of 0.0570. Conclusion: In this healthy Asian cohort, a purely genetic prediction model for moderate-severe subclinical coronary atherosclerosis did not perform as well as its clinical counterpart. Incorporating both clinical and genetic variables allowed for only minor incremental predictive capabilities.
- Open Access
- 17 December 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (41) , 106232
Heroes of Zero
- 17 December 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (41) , 106232
Open AccessHeroes of Zero